ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 6th April, 2020 on account of Mahavir Jayanti.

ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%
Fri, 20 Mar 03:02 PM

ASTRAZENECA PHARMA share price has zoomed 13% and is presently trading at Rs 2,429.

Meanwhile, the BSE HEALTHCARE Index is at 12,166 (up 5.2%).

Among the top Gainers in the BSE HEALTHCARE Index today are ASTRAZENECA PHARMA (up 13.3%) and ABBOTT INDIA (up 13.8%).

FDC LTD. (down 0.2%) and AJANTA PHARMA (down 0.3%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,938 to Rs 2,429, registering a gain of Rs 491 (up 21.3%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 12,166, loss of 2,104 points (down 15.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 105.4%), J.B.CHEMICALS (up 56.0%) and IPCA LABS (up 52.3%).

One Stock Crorepati: The Biggest Money-Making Opportunity Available Right Now

What About the Benchmark Indices?

The BSE Sensex is at 30,418 (up 5.1%).

The top gainers among the BSE Sensex stocks today are ONGC (up 17.7%), HUL (up 11.2%) and RELIANCE IND. (up 10.1%). Other gainers include TCS (up 9.2%) and ULTRATECH CEMENT (up 8.7%). The most traded stocks in the BSE Sensex are ONGC and SBI.

In the meantime, NSE Nifty is at 8,883 (up 5.2%). The top gainers in the NSE Nifty include ONGC (up 17.9%), GAIL (up 14.9%) and BHARTI INFRATEL (up 14.9%). Other gainers include DR. REDDYS LAB (up 11.3%) and HUL (up 11.0%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 30,418, registering a loss of 7,945 points (down 22.48%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 144 million for the quarter ended September 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 3.1% to Rs 2.1 billion during the period as against Rs 2.2 billion in July-September 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 78.5x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
FREE Guide for You: Find the Next Crorepati Stock in this Futuristic Industry
Tanushree Banerjee, the co-head of research, just shared her latest guide: 'Find the Next Crorepati Stock in this Futuristic Industry' And she has agreed to make it available for free for a limited time. If you've not claimed your free copy, then do so now. It might not remain free for long. Click Here to Download the Guide

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Surges by 13%; BSE HEALTHCARE Index Up 5.2%". Click here!

  

Stock Market Updates

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling (Today's Market)

Apr 3, 2020 Closing

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

NOCIL Plunges by 5%; BSE 500 Index Down 1.8% (Today's Market)

Apr 3, 2020 03:33 PM

NOCIL share price has plunged by 5% and its current market price is Rs 68. The BSE 500 is down by 1.8%. The top gainers in the BSE 500 Index are GUJARAT ALKALIES (up 13.9%) and LUPIN (up 13.4%). The top losers are NOCIL (down 5.2%) and 3M INDIA (down 5.0%).

INDIAN ENERGY EXCHANGE LTD Surges by 5%; BSE POWER Index Down 0.3% (Today's Market)

Apr 3, 2020 03:31 PM

INDIAN ENERGY EXCHANGE LTD share price has surged by 5% and its current market price is Rs 137. The BSE POWER is down by 0.3%. The top gainers in the BSE POWER Index are INDIAN ENERGY EXCHANGE LTD (up 5.4%) and RELIANCE INFRA (up 5.0%). The top losers are KALPATARU POWER (down 0.1%) and TORRENT POWER LTD (down 0.3%).

LIC HOUSING Plunges by 5%; BSE 500 Index Down 1.8% (Today's Market)

Apr 3, 2020 03:27 PM

LIC HOUSING share price has plunged by 5% and its current market price is Rs 234. The BSE 500 is down by 1.8%. The top gainers in the BSE 500 Index are LUPIN (up 14.0%) and RAJESH EXPORTS (up 11.7%). The top losers are LIC HOUSING (down 5.2%) and MARUTI SUZUKI (down 5.4%).

AJANTA PHARMA Plunges by 5%; BSE HEALTHCARE Index Up 3.5% (Today's Market)

Apr 3, 2020 03:27 PM

AJANTA PHARMA share price has plunged by 5% and its current market price is Rs 1,414. The BSE HEALTHCARE is up by 3.5%. The top gainers in the BSE HEALTHCARE Index are LUPIN (up 14.0%) and SUN PHARMA (up 9.4%). The top losers are AJANTA PHARMA (down 5.1%) and STRIDES PHARMA SCIENCE (down 5.3%).

PERSISTENT SYSTEMS Plunges by 7%; BSE IT Index Down 2.7% (Today's Market)

Apr 3, 2020 03:25 PM

PERSISTENT SYSTEMS share price has plunged by 7% and its current market price is Rs 545. The BSE IT is down by 2.7%. The top gainers in the BSE IT Index are ORACLE FINANCIAL (up 5.0%) and ECLERX SERVICES (up 3.0%). The top losers are PERSISTENT SYSTEMS (down 7.0%) and L&T TECHONOLOGY (down 6.0%).

View More Indian Share Market News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Apr 3, 2020 (Close)

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.